ERCHF- News
Grant of Options
On 19 May 2009 the Board of Eden Research plc ("Eden") granted options to the following directors under the terms of its Share Option Scheme:
Director Share options granted Total options held
Ken Brooks 900,000 2,878,487
Timothy Griffiths 900,000 2,878,487
Alex Abrey 450,000 550,000
Clive Newitt 150,000 225,000
Stephen O'Brien 100,000 100,000
Sir Ben Gill 100,000 100,000
The new options can be exercised at a price of 26 pence per share and have been granted in recognition of the directors' efforts over the past three years to bring Eden towards commercialisation and as a result of the Company's low remuneration policy. The options can be exercised any time up to 19 May 2014.
For further information:
Tim Griffiths, Chief Executive Eden Research plc Tel: 01993 868844
Matthew Robinson FinnCap Tel: 020 7600 1658
ABOUT EDEN RESEARCH PLC
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.
Before you criticize a man, walk a mile in his shoes. That way, if he gets angry, he's a mile away and barefoot.
News 
Market Data 
Discover 
